Abstract
A series of aryloxyazetidines, aryloxypyrrolidines and aryloxypiperidines were designed based on structural overlap with previously reported arylpyrazine Oxytocin antagonists. Similarly high levels of Oxytocin antagonism were achievable in these new series. Several aryloxyazetidines also showed high levels of selectivity, with one compound, 25, displaying promising in vivo pharmacokinetics and significantly improved aqueous solubility over related compounds containing a biaryl substituent. © 2009 Elsevier Ltd. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Brown, A., Brown, T. B., Calabrese, A., Ellis, D., Puhalo, N., Ralph, M., & Watson, L. (2010). Triazole oxytocin antagonists: Identification of an aryloxyazetidine replacement for a biaryl substituent. Bioorganic and Medicinal Chemistry Letters, 20(2), 516–520. https://doi.org/10.1016/j.bmcl.2009.11.097
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.